Live
- Saini pays tribute at Nada Sahib Gurudwara
- TGCHE revamps undergraduate courses: Chairman
- Hyderabad ideal for chip manufacturing: Sridhar Babu
- For centuries, villagers refrain from meat, alcohol on Sundays
- Metro Rail: First batch of cheques given to affected property owners
- CM expresses concern over declining fertility
- Hyderabad: Even before summer sets in, water woes grip parts of city
- Importance of Poly Techfests stressed
- Vegetable grafting unit at Hisar university opened
- New scheme likely to replace Aarogyasri
Alembic Pharma gets 4 FDA observations
Drug firm Alembic Pharmaceuticals on Monday said it has received four observations from the US health regulator after the inspection of Panelav facility.
New Delhi : Drug firm Alembic Pharmaceuticals on Monday said it has received four observations from the US health regulator after the inspection of Panelav facility. "The formulations facility of the company at Panelav, Halol was inspected by the USFDA from March 21 to 25. The company had received four observations which are being addressed by our regulator and quality team," Alembic Pharmaceuticals said.
The company, however, did not provide any details about the observations it has received from the United States Food and Drug Administration (USFDA). According to the company's website, formulations accounts for around 65 per cent of the total business for Alembic Pharmaceuticals. It has three manufacturing facility for formulations Vadodara and Panelav at Gujarat and Baddi in Himachal Pradesh.
